Gopinath Rongala

Title: Gopinath Rongala: Innovator in Beta-Lactamase Inhibitors

Introduction

Gopinath Rongala is a notable inventor based in Malvern, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of beta-lactamase inhibitors. His innovative work has led to the filing of a patent that addresses critical challenges in bacterial treatment.

Latest Patents

Gopinath Rongala holds a patent for a compound titled "Citrate coordination complex of an orally-delivered beta-lactamase inhibitor and uses thereof." This patent discloses a compound that is (R)-(2-(3-((((2-ethylbutanoyl)oxy)methoxy)carbonyl)-2-hydroxyphenyl)-1-propionamidoethyl)boronic acid citrate coordination complex, or a pharmaceutically acceptable salt or solvate thereof. The patent also outlines methods for treating bacterial infections using this compound in combination with ceftibuten. He has 1 patent to his name.

Career Highlights

Gopinath Rongala is currently associated with Venatorx Pharmaceuticals, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in beta-lactamase inhibitors has positioned him as a key player in the development of new therapeutic strategies.

Collaborations

Gopinath has collaborated with notable colleagues such as Anthony Drager and Allison L Zulli. Their combined efforts contribute to the advancement of research and development in their field.

Conclusion

Gopinath Rongala's work in the pharmaceutical sector, particularly with beta-lactamase inhibitors, showcases his commitment to innovation and improving treatment options for bacterial infections. His contributions are significant in the ongoing battle against antibiotic resistance.